SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?


To: H James Morris who wrote (84714)11/20/1999 3:56:00 PM
From: re3  Read Replies (2) | Respond to of 164684
 
james, this article says there are 267 billionaires in the us of a...with this mania i thought there'd be more...where are you on the list <ggg>

afr.com.au



To: H James Morris who wrote (84714)11/20/1999 6:53:00 PM
From: Tom D  Read Replies (1) | Respond to of 164684
 
There is considerable optimism built into the share price.

I would take the profits and run, since horrendous competition will be emerging in this field. There are already over 2 dozen handheld prescription writing companies. Allscripts is ahead of some of them because they are offering an incremental revenue stream to physicians. But the whole problem is creating enough revenues to motivate doctors to embrace electronics, and to offset the tremendous time requirements for use of the devices. I expect there will be other companies who will create more compelling reasons for doctors to get wired than Allscripts can.

In addition, while there are 750,000 doctors in the US, only a minority of them are candidates for the Allscripts prescription writer, due to prior alliances, and the structure of their medical groups.

I am skeptical.

Tom



To: H James Morris who wrote (84714)11/20/1999 7:17:00 PM
From: Tom D  Read Replies (2) | Respond to of 164684
 
Addendum...

IMHO, they are putting one past Wall Street. Claiming to be the industry leader is a lie. ProxyMed has tens of thousands more physicians prescribing than AllScripts, and half their market cap. Everybody and their grandmother is making handheld prescription writers, from Healtheon, to Proxymed, to Advanced Health to IScribe to many online pharmacies. A year from now, MDRXs prospects will be very guarded. I don't know how much longer the fools will bid up the price, but I'd sell, if I were you.

quicken.excite.com

Tom D